SNUGGLE WARM 4000 CONVECTIVE WARMING SYSTEM, MODEL SW4000

K040632 · Smiths Medical Asd, Inc. · DWJ · Apr 27, 2004 · Cardiovascular

Device Facts

Record IDK040632
Device NameSNUGGLE WARM 4000 CONVECTIVE WARMING SYSTEM, MODEL SW4000
ApplicantSmiths Medical Asd, Inc.
Product CodeDWJ · Cardiovascular
Decision DateApr 27, 2004
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.5900
Device ClassClass 2
AttributesTherapeutic

Intended Use

The device is intended for thermal regulating a patient's temperature to prevent hypothermia by a warm air heated blanket to reduce cold discomfort during and after surgical procedures.

Device Story

The Sterile Cardiac Blanket is a component of the Snuggle Warm 4000 Convective Warming System. It functions by receiving forced warm air from a convective warming unit through a connecting hose; the air inflates the blanket, which is placed on the patient to provide thermal regulation. Used in clinical settings during and after surgical procedures, the device is operated by healthcare professionals. The blanket helps maintain patient normothermia, preventing hypothermia and reducing cold discomfort. The sterile version provides the same warming functionality as the predicate non-sterile blankets, with added sterility for surgical environments.

Clinical Evidence

Bench testing only. Testing conducted per ASTM F 2196-02 verified that the blanket maintains a maximum contact surface temperature ≤ 48.0°C and an average contact surface temperature ≤ 46.0°C. Robustness was confirmed via burst pressure testing and tape strength analysis pre- and post-ethylene oxide sterilization, demonstrating minimal negative effects from the sterilization process.

Technological Characteristics

Convective warming blanket; forced air heating principle. Materials and design identical to predicate. Complies with ASTM F 2196-02 for temperature management. Sterilization via ethylene oxide.

Indications for Use

Indicated for patients undergoing surgical procedures to prevent hypothermia and reduce cold discomfort during and after surgery.

Regulatory Classification

Identification

A thermal regulating system is an external system consisting of a device that is placed in contact with the patient and a temperature controller for the device. The system is used to regulate patient temperature.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Special 510(k) Premarket Notification Sterile Cardiac Blanket (SW2008) March 9, 2004 APR 2 7 2004 Smiths Medical ASD, Inc. Ko40632 160 Weymouth Street Rockland, MA 02370 ## Regulatory Submission Summary 510(k) Summary of Safety and Effectiveness Page 1 of 2 The 510(k) Summary of Safety and Effectiveness is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. | SUBMITTER NAME: | Smiths Medical ASD, Inc. | |-----------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | SUBMITTER ADDRESS: | 160 Weymouth<br>Rockland MA 02370 | | CONTACT PERSON: | Vernon Trimble<br>Director of Regulatory Affairs/Quality Assurance | | PHONE NUMBER:<br>FAX NUMBER:<br>SUMMARY DATE: | 781-878-8011<br>781-878-7540<br>March 9, 2004 | | DEVICE TRADE NAME: | Sterile Cardiac Blanket (a component of Snuggle Warm® 4000<br>Convective Warming System) | | COMMON NAME: | Convective Warming Blanket (a component of Convective<br>Warming System). | | DEVICE CLASSIFICATION NAME: | The FDA has classified Thermal Regulation Systems as Class II<br>devices under CFR Title 21, Section 870.5900. The product code<br>is DWJ. | | PREDICATE DEVICE: | Snuggle Warm® 4000 Convective Warming System that includes<br>non-sterile Convective Warming Blankets (Model SW4000) | | DEVICE DESCRIPTION: | The Snuggle Warm® 4000 Convective Warming System consists<br>of a Convective Warming Unit, a hose that connects to the<br>Convective Warming Unit on one end and connects to a blanket<br>on the other end. The forced warm air travels from the Warming<br>unit through the hose to the blanket that is placed on the patient. | | INDICATIONS FOR USE: | The device is intended for thermal regulating a patient's<br>temperature to prevent hypothermia by a warm air heated<br>blanket to reduce cold discomfort during and after surgical<br>procedures. | | TECHNOLOGICAL<br>CHARACTERISTICS: | The proposed device has the same technological characteristics<br>(i.e., design, material, chemical composition)as the predicate | Proprietary and Confidential Information of Smiths Medical ASD, Inc. 2040632 {1}------------------------------------------------ ### Requlatory Submission Summary 510(k) Summary of Safety and Effectiveness Page 2 of 2 # SUMMARY OF PERFORMANCE TESTING: #### Maximum Temperature delivered to the patient: . The Sterile Cardiac Blanket was tested in accordance to the ASTM F 2196-02 Standard Specification for Circulating Liquid and Forced Air Patient Temperature Management Devices. This testing verified that the Sterile Cardiac Blanket maintained a maximum contact surface temperature of not exceeding 48.0℃ and an average contact surface temperature of not exceeding 46.0°C in normal condition. #### Burst Pressure-Pre/post sterilization: . The Burst Pressure of the Sterile Cardiac Blanket was tested in the same manner as the currently marketed non-sterile Convective Warming Blankets were inflated until bursting, and the burst pressure was measured. The Sterile Cardiac Blanket met the same robustness requirements, as do the predicate blankets. #### . Tape Strength-Pre and Post Sterilization: The tensile strength of the tape bond was measured pre and post sterilization, and after 3 levels of ethylene oxide exposure. While 3 levels of ethylene oxide dosage would represent a worstcase scenario. Test results indicate that sterilization have minimal negative effects on the tape adhesive. ### CONCLUSION: The Sterile Cardiac Blanket performs as intended according to its performance specifications. The Sterile Cardiac Blanket is substantially equivalent to the predicate device (that includes non-sterile blankets). The Sterile Cardiac Blanket is substantially equivalent to the non-sterile blanket with respect to the intended use as a component of the Snuggle Warm® 4000 Convective Warming System Proprietary and Confidential Information of Smiths Medical ASD, Inc. {2}------------------------------------------------ Image /page/2/Picture/11 description: The image is a black and white seal for the Department of Health & Human Services. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the top half of the circle. In the center of the seal is a stylized image of an eagle with its wings spread. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 2 7 2004 Smiths Medical ASD, Inc. c/o Mr. Vernon Trimble Director of Regulatory/Affairs/Quality Assurance 160 Weymouth Street Rockland, MA 02370 Re: K040632 Snuggle Warm 4000 Convective Warming System, Model SW4000 Regulation Number: 21 CFR 870.5900 Regulation Name: Thermal Regulatory System Regulatory Class: Class II (two) Product Code: DWJ Dated: March 31, 2004 Received: April 2, 2004 Dear Mr. Trimble: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 – Mr. Vernon Trimble Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, ua R. Varliner Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Indications for Use 510(k) Number (if known): ко40632 . Device Name: Sterile Cardiac Blanket _ Indications For Use: The device is intended for thermal regulating a patient's temperature to prevent hypothermia by a warm air heated blanket to reduce cold discomfort during and after surgical procedures. X Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Dana P. Vachmer (Division Sign-Off) (Division Sign-Off) Division of Cardiovascular Devices Biolors 510(k) Number Kodu Costo Costo Cost Page 1 of ____________________________________________________________________________________________________________________________________________________________________
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...